Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab

NCT01249937 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Ranibizumab
DRUG: Triamcinolone Acetonide

Sponsor

University Health Network, Toronto